Clinical, Metabolic and Endocrine Parameters in Response to Metformin in Obese Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind and Placebo-Controlled Trial-Reference-Cited by-同舟云学术

Clinical, Metabolic and Endocrine Parameters in Response to Metformin in Obese Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind and Placebo-Controlled Trial

Published:2003-02 Issue:2 Volume:35 Page:86-91
ISSN:0018-5043
Container-title:Hormone and Metabolic Research
language:en
Short-container-title:Horm Metab Res

Author:

Chou K. H.,von Eye Corleta H.,Capp E.,Spritzer P. M.

Publisher

Georg Thieme Verlag KG

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2003-39056.pdf

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin-induced PCSK9 inhibition further decreases LDL-C following statin treatment in patients with coronary artery disease and without diabetes;Journal of Cardiovascular Pharmacology;2024-05-21

2. Impact of insulin sensitization on metabolic and fertility outcomes in women with polycystic ovary syndrome and overweight or obesity—A systematic review, meta‐analysis, and meta‐regression;Obesity Reviews;2024-04-04

3. Are steroid hormones and autistic traits affected by metformin? First insights from a pilot;Comprehensive Psychoneuroendocrinology;2023-11

4. The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials;European Journal of Endocrinology;2023-08

5. Metabolic complications of glucocorticoids – Prevention by metformin;Annales d'Endocrinologie;2023-08